Industry praise for Brexit pragmatism

The drug development industry has welcomed the UK government’s position paper seeking a smooth and orderly withdrawal from the European Union (EU) in regard to the availability of goods, in a way that supports the move to the freest possible future economic relationship.

This paper, entitled Continuity in the availability of goods for the EU and the UK, was published on Monday and makes the UK government position somewhat clearer on what the future relationship with the EU will look like on these key issues for investors and businesses once Brexit has happened and during the transition period.

“The UK’s ambition is to work towards a comprehensive future agreement with the EU, which includes securing the freest and most frictionless trade possible in goods and services, to the benefit of all,” the paper states. “The UK enters these discussions with this in mind, and is seeking to avoid any unnecessary disruption during the move to the future partnership."